Secarna Pharmaceuticals GmbH & Co. KG | WebDisclosure

Basculer en Français

9803	Companies
196616	Keywords
127635	Articles
104537	Press releases

Headlines Articles Press releases Secarna Pharmaceuticals GmbH & Co. KG

Home
Companies
Secarna Pharmaceuticals GmbH & Co. KG

BRIEF

published on 05/23/2025 at 09:05, 8 months 12 days ago

Secarna Pharmaceuticals dévoile des données prometteuses sur le SECN-15 à l'ASCO 2025

Essai Clinique Secarna Pharmaceuticals Thérapie Contre Le Cancer Oligonucléotide Antisens SECN-15
PRESS RELEASE

published on 05/23/2025 at 09:00, 8 months 12 days ago

Secarna Pharmaceuticals to present new data and clinical strategy for lead antisense oligonucleotide program SECN-15 at ASCO 2025
Secarna Pharmaceuticals to present new data and clinical strategy for SECN-15 at ASCO 2025. Targeting NRP1 with antisense oligonucleotides for solid cancers. Promising therapeutic approach

Secarna Pharmaceuticals Antisense Oligonucleotides SECN-15 ASCO 2025 Clinical Strategy
BRIEF

published on 05/12/2025 at 14:05, 8 months 23 days ago

Secarna Pharmaceuticals et Curie.Bio signent un accord de recherche

Collaboration Biopharmaceutique Découverte De Médicaments Thérapeutiques Par Oligonucléotides Accord De Recherche Plateforme Dotée D'IA
BRIEF

published on 05/12/2025 at 14:05, 8 months 23 days ago

Secarna Pharmaceuticals and Curie.Bio Sign Research Agreement

Drug Discovery Biopharmaceutical Collaboration Oligonucleotide Therapeutics Research Agreement AI-empowered Platform
PRESS RELEASE

published on 05/12/2025 at 14:00, 8 months 23 days ago

Secarna Pharmaceuticals and Curie.Bio Portfolio Company Enter into Research and Option Agreement
Secarna Pharmaceuticals and Curie.Bio Portfolio Company signed a research and option agreement to accelerate the discovery of novel oligonucleotide therapies

Research Option Agreement Secarna Pharmaceuticals Curie.Bio Oligonucleotide Therapies
BRIEF

published on 04/28/2025 at 14:35, 9 months 6 days ago

Prof. Dr. Vignali Joins Secarna Pharmaceuticals' Scientific Board

Scientific Advisory Board Immuno-oncology Secarna Pharmaceuticals SECN-15 Prof. Dr. Vignali
BRIEF

published on 04/28/2025 at 14:35, 9 months 6 days ago

Le professeur Vignali rejoint le conseil scientifique de Secarna Pharmaceuticals

Immuno-oncologie Secarna Pharmaceuticals Conseil Consultatif Scientifique SECN-15 Prof. Dr. Vignali
PRESS RELEASE

published on 04/28/2025 at 14:30, 9 months 6 days ago

Secarna Pharmaceuticals adds leading expert to Scientific Advisory Board with appointment of Prof. Dr. Vignali
Secarna Pharmaceuticals appoints Prof. Dr. Dario Vignali to Scientific Advisory Board, enhancing expertise in oncology research and immunotherapy strategies for solid tumors

Scientific Advisory Board Immunotherapy Oncology Research Secarna Pharmaceuticals Prof. Dr. Dario Vignali
BRIEF

published on 03/26/2025 at 14:05, 10 months 9 days ago

Secarna Pharmaceuticals présente des données prometteuses sur SECN-15 à l'AACR

Thérapie Contre Le Cancer Inhibiteurs De Points De Contrôle SECN-15 Microenvironnement Tumoral Ciblage NRP1
BRIEF

published on 03/26/2025 at 14:05, 10 months 9 days ago

Secarna Pharmaceuticals Highlights Promising Data on SECN-15 at AACR

Cancer Therapy Checkpoint Inhibitors SECN-15 Tumor Microenvironment NRP1 Targeting

Accesswire

Published on 02/04/2026 at 18:00, 2 hours 2 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 3 hours 47 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 4 hours 17 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 5 hours 2 minutes ago

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 14:30, 5 hours 32 minutes ago

Datametrex Expands Business In Data Centres

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 18:55, 1 hour 7 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 1 hour 22 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:34, 1 hour 27 minutes ago

E-PANGO: Composition du capital au 31 janvier 2026
Published on 02/04/2026 at 18:14, 1 hour 48 minutes ago

Issue of Equity
Published on 02/04/2026 at 18:05, 1 hour 57 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL

Les Echos

Published on 02/04/2026 at 18:04, 1 hour 58 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 1 hour 58 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 2 hours 17 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 2 hours 17 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 2 hours 17 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE